Allstate (NYSE:ALL) Given a $202.00 Price Target by Wells Fargo & Company Analysts

Allstate (NYSE:ALL) has been assigned a $202.00 price target by Wells Fargo & Company in a research note issued to investors on Tuesday, MarketBeat reports. The brokerage presently has an “equal weight” rating on the insurance provider’s stock. Wells Fargo & Company‘s price objective indicates a potential downside of 3.34% from the stock’s previous close.

ALL has been the topic of several other research reports. Evercore ISI raised their target price on Allstate from $227.00 to $230.00 and gave the company an “outperform” rating in a research report on Thursday, May 1st. BMO Capital Markets restated an “outperform” rating on shares of Allstate in a research report on Friday, May 16th. Morgan Stanley raised their target price on Allstate from $235.00 to $245.00 and gave the company an “overweight” rating in a research report on Friday, August 1st. Barclays restated an “underweight” rating and issued a $198.00 target price (up previously from $188.00) on shares of Allstate in a research report on Thursday, July 31st. Finally, UBS Group raised their target price on Allstate from $230.00 to $235.00 and gave the company a “buy” rating in a research report on Wednesday, July 9th. One research analyst has rated the stock with a sell rating, one has given a hold rating, fifteen have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $230.00.

Allstate Stock Performance

Shares of ALL stock opened at $208.99 on Tuesday. The company has a market capitalization of $55.07 billion, a P/E ratio of 9.83, a P/E/G ratio of 0.86 and a beta of 0.35. The business’s 50 day moving average is $198.41 and its two-hundred day moving average is $197.54. The company has a current ratio of 0.43, a quick ratio of 0.43 and a debt-to-equity ratio of 0.37. Allstate has a 12-month low of $169.20 and a 12-month high of $213.18.

Allstate (NYSE:ALL) last issued its quarterly earnings results on Wednesday, July 30th. The insurance provider reported $5.94 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.20 by $2.74. The company had revenue of $15.05 billion for the quarter, compared to the consensus estimate of $16.59 billion. Allstate had a return on equity of 28.74% and a net margin of 8.79%. Allstate’s revenue for the quarter was up 5.8% on a year-over-year basis. During the same quarter in the prior year, the business posted $1.61 earnings per share. Analysts expect that Allstate will post 18.74 EPS for the current fiscal year.

Institutional Investors Weigh In On Allstate

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Rehmann Capital Advisory Group grew its stake in shares of Allstate by 3.2% in the first quarter. Rehmann Capital Advisory Group now owns 1,630 shares of the insurance provider’s stock valued at $338,000 after buying an additional 51 shares in the last quarter. Vantage Point Financial LLC grew its stake in shares of Allstate by 3.6% in the first quarter. Vantage Point Financial LLC now owns 1,495 shares of the insurance provider’s stock valued at $310,000 after buying an additional 52 shares in the last quarter. Confluence Wealth Services Inc. grew its stake in shares of Allstate by 0.7% in the first quarter. Confluence Wealth Services Inc. now owns 8,000 shares of the insurance provider’s stock valued at $1,558,000 after buying an additional 54 shares in the last quarter. Linscomb Wealth Inc. grew its stake in shares of Allstate by 1.3% in the first quarter. Linscomb Wealth Inc. now owns 4,079 shares of the insurance provider’s stock valued at $845,000 after buying an additional 54 shares in the last quarter. Finally, Ancora Advisors LLC grew its stake in shares of Allstate by 0.7% in the first quarter. Ancora Advisors LLC now owns 8,402 shares of the insurance provider’s stock valued at $1,740,000 after buying an additional 55 shares in the last quarter. Institutional investors and hedge funds own 76.47% of the company’s stock.

Allstate Company Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.